Coloplast A/S (FRA:CBHD)

Market Cap	18.75B
Revenue (ttm)	3.74B
Net Income (ttm)	546.27M
Shares Out	n/a
EPS (ttm)	2.42
PE Ratio	34.32
Forward PE	23.59
Dividend	2.95 (3.52%)
Ex-Dividend Date	May 8, 2025

Volume	259
Average Volume	153
Open	82.62
Previous Close	83.22
Day's Range	82.62 - 85.04
52-Week Range	78.86 - 126.65
Beta	n/a
RSI	59.54
Earnings Date	Aug 19, 2025

About Coloplast

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the B...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1954
• Employees: 16,639
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CBHD

Financial Performance

In 2024, Coloplast's revenue was 27.03 billion, an increase of 10.33% compared to the previous year's 24.50 billion. Earnings were 5.05 billion, an increase of 5.62%.

Financial numbers in DKK